References
- 1Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves’ ophthalmopathy. Thyroid. 2002; 12:855-60.1248776710.1089/105072502761016476WiersingaWMBartalenaLEpidemiology and prevention of Graves’ ophthalmopathyThyroid20021285560
- 2Lehmann GM, Feldon SE, Smith TJ, Phipps RP. Immune mechanisms in thyroid eye disease. Thyroid. 2008; 18:959-65.10.1089/thy.2007.040718752427LehmannGMFeldonSESmithTJPhippsRPImmune mechanisms in thyroid eye diseaseThyroid20081895965
- 3G rdal C, Sara O, Gen I, Kirimlioglu H, Takmaz T, Can I. Ocular surface and dry eye in Graves’ disease. Curr Eye Res. 2011; 36:8-13.2117459210.3109/02713683.2010.526285Grdal CSaraOGenIKirimliogluHTakmazTCanIOcular surface and dry eye in Graves’ diseaseCurr Eye Res201136813
- 4Versura P, Campos EC. The ocular surface in thyroid diseases. Curr Opin Allergy Clin Immunol. 2010; 10: 486-92.10.1097/ACI.0b013e32833e1749VersuraPCamposECThe ocular surface in thyroid diseasesCurr Opin Allergy Clin Immunol20101048692
- 5Ismailova DS, Fedorov AA, Grusha YO. Ocular surface changes in thyroid eye disease. Orbit 2013; 32:87-90.2356576310.3109/01676830.2013.764440IsmailovaDSFedorovAAGrushaYOOcular surface changes in thyroid eye diseaseOrbit2013328790
- 6The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5:93-107.17508117The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf2007593107
- 7Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009; 3:405-12.19688028GaytonJLEtiology, prevalence, and treatment of dry eye diseaseClin Ophthalmol2009340512
- 8Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008; 158:273-85.1829945910.1530/EJE-07-0666BartalenaLBaldeschiLDickinsonAEcksteinAKendall-TaylorPMarcocciCet alConsensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GOEur J Endocrinol200815827385
- 9Weetman AP. Graves’ disease. N Engl J Med. 2000; 343:1236-48.1107167610.1056/NEJM200010263431707WeetmanAPGraves’ diseaseN Engl J Med2000343123648
- 10Naik VM, Naik MN, Goldberg RA, Smith TJ, Douglas RS. Immunopathogenesis of thyroid eye disease: emerging paradigms. Surv Ophthalmol. 2010; 55: 215-26.10.1016/j.survophthal.2009.06.00920385333NaikVMNaikMNGoldbergRASmithTJDouglasRSImmunopathogenesis of thyroid eye disease: emerging paradigmsSurv Ophthalmol20105521526
- 11Kasetsuwan N, Gorvanich S, Erjongmanee S, Thienprasiddhi P, Jitapunkul S. Prevalence of dry eyes in elderly Thai population (the Romklao eye study). Asian Biomed. 2012; 6:875-82.KasetsuwanNGorvanichSErjongmaneeSThienprasiddhiPJitapunkulSPrevalence of dry eyes in elderly Thai population (the Romklao eye study)Asian Biomed2012687582
- 12Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmol. 2003; 110:1096-101.10.1016/S0161-6420(03)00262-8LinPYTsaiSYChengCYLiuJHChouPHsuWMPrevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye StudyOphthalmol20031101096101
- 13Gupta A, Sadeghi PB, Akpek EK. Occult thyroid eye disease in patients presenting with dry eye symptoms. Am J Ophthalmol. 2009; 147:919-23.10.1016/j.ajo.2008.12.00719211095GuptaASadeghiPBAkpekEKOccult thyroid eye disease in patients presenting with dry eye symptomsAm J Ophthalmol200914791923
- 14Naseem M, Donker DL, Paridaens D. Blepharoptosis as a sign of severe Graves’ orbitopathy. Eye 2009; 23: 1743-4.10.1038/eye.2008.333NaseemMDonkerDLParidaensDBlepharoptosis as a sign of severe Graves’ orbitopathyEye20092317434
- 15Nowak M, Marek B, Kos-Kudla B, Kajdaniuk D, Sieminska L. [Tear film profile in patients with active thyroid orbitopathy]. Klin Oczna. 2005; 107:479-82. [in Polish, English abstract]16417002NowakMMarekBKos-KudlaBKajdaniukDSieminskaL[Tear film profile in patients with active thyroid orbitopathy]Klin Oczna200510747982
- 16Eckstein AK, Finkenrath A, Heiligenhaus A, Renzing-Kohler K, Esser J, Kruger C, et al. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand. 2004; 82:291-7.EcksteinAKFinkenrathAHeiligenhausARenzing-KohlerKEsserJKrugerCet alDry eye syndrome in thyroid-associated ophthalmopathylacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodiesActa Ophthalmol Scand200482
- 17Yoon JS, Choi SH, Lee JH, Lee SJ, Lee SY. Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol. 2010; 248:271-6.10.1007/s00417-009-1215-219844736YoonJSChoiSHLeeJHLeeSJLeeSYOcular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathyGraefes Arch Clin Exp Ophthalmol20102482716
- 18Villani E, Viola F, Sala R, Salvi M, Mapelli C, Curro N, et al. Corneal involvement in Graves’ orbitopathy: an in vivo confocal study. Invest Ophthalmol. 2010; 51: 4574-8.10.1167/iovs.10-5380VillaniEViolaFSalaRSalviMMapelliCCurroNet alCorneal involvement in Graves’ orbitopathy: an in vivo confocal studyInvest Ophthalmol20105145748
- 19Bruscolini A, Abbouda A, Locuratolo N, Restivo L, Trimboli P, Romanelli F. Dry eye syndrome in non-exophthalmic Graves’ disease. Semin Ophthalmol. 2014.24460515BruscoliniAAbboudaALocuratoloNRestivoLTrimboliPRomanelliFDry eye syndrome in non-exophthalmic Graves’ diseaseSemin Ophthalmol2014
- 20Iskeleli G, Karakoc Y, Abdula A. Tear film osmolarity in patients with thyroid ophthalmopathy. Jpn J Ophthalmol. 2008; 52:323-6.10.1007/s10384-008-0545-718773272IskeleliGKarakocYAbdulaATear film osmolarity in patients with thyroid ophthalmopathyJpn J Ophthalmol2008523236